Double-blinded, randomised, placebo-controlled trial of convalescent plasma for COVID-19: analyses by neutralising antibodies homologous to donors’ variants
Khawaja et al., Infectious Diseases, doi:10.1080/23744235.2024.2329957
https://c19early.org/khawaja.html